Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)

NCT05312918 · clinicaltrials.gov ↗
UNKNOWN
Status
603
Enrollment
OTHER_GOV
Sponsor class

Conditions

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators